913574-42-2

Basic information

• Product Name: N-(1-(2,2-difluoro-2-(4-(trifluoromethyl)phenyl)ethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
• Synonyms: N-(1-(2,2-difluoro-2-(4-(trifluoromethyl)phenyl)ethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine;N-(1-(2,2-difluoro-2-(4-(trifluoroMethyl)phenyl)ethyl)piperidin-;N-[1-[2,2-Difluoro-2-[4-(trifluoromethyl)phenyl]ethyl]-4-piperidinyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine;N-(1-(2,2-Difluoro-2-(4-(trifluoromethyl)phenyl)ethyl)-piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidi;N-(1-(2,2-Difluoro-2-(4-(trifluoromethyl);N-(1-(2,2-Difluoro-2-(4-(trifluoromethyl)phenyl)ethyl)-piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrim;{1-[2,2-Difluoro-2-(4-trifluoromethyl-phenyl)-ethyl]-piperidin-4-yl}-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)-amine
• CAS NO: 913574-42-2
• Molecular Formula: C19H19F5N6
• Molecular Weight: 426
• Mol File: 913574-42-2.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Density: 1.430
• CAS DataBase Reference: N-(1-(2,2-difluoro-2-(4-(trifluoromethyl)phenyl)ethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(1-(2,2-difluoro-2-(4-(trifluoromethyl)phenyl)ethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine(913574-42-2)
• EPA Substance Registry System: N-(1-(2,2-difluoro-2-(4-(trifluoromethyl)phenyl)ethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine(913574-42-2)

Safety Data

• Hazardous Substances Data: 913574-42-2(Hazardous Substances Data)

Usage

General Description

The chemical compound "N-(1-(2,2-difluoro-2-(4-(trifluoromethyl)phenyl)ethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine" is a complex organic molecule that belongs to the pyrazolo[3,4-d]pyrimidinamine class. It contains a piperidine ring and a pyrazole ring structure attached to a difluoroethyl group and a trifluoromethylphenyl group. N-(1-(2,2-difluoro-2-(4-(trifluoromethyl)phenyl)ethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine is primarily used as a pharmaceutical intermediate in the synthesis of potential drug candidates, particularly in the development of treatments for various diseases or conditions. It may have potential applications in the fields of medicinal chemistry and drug discovery due to its unique structural features and potential biological activities. Careful handling and proper safety precautions are necessary when working with this chemical due to its complex structure and potential biological activity.

InChI:InChI=1S/C19H19F5N6/c20-18(21,12-1-3-13(4-2-12)19(22,23)24)10-30-7-5-14(6-8-30)28-16-15-9-27-29-17(15)26-11-25-16/h1-4,9,11,14H,5-8,10H2,(H2,25,26,27,28,29)

Upstream product

• 73789-96-5 ethyl α,α-difluoro-4-(trifluoromethyl)benzeneacetate 
• 5399-92-8 4-chloro-1H-pyrazolo[3,4-d]pyrimidine 
• 455-13-0 4-Iodobenzotrifluoride 

Relevant articles and documents

TREATMENT OF ANXIETY DISORDERS AND AUTISM SPECTRUM DISORDERS

Disclosed are methods for treating autism spectrum disorders and/or anxiety disorders by administering certain NR2B subunit-selective NMDA (N methyl-D aspartate) antagonists. Anxiety disorders include agoraphobia (with or without panic disorder), generalized anxiety disorder (GAD), social anxiety disorder (SAD), panic disorder (PD), post-traumatic stress disorder (PTSD) and obsessive-compulsive disorder (OCD).